A pharmaceutical composition comprising synergistically effective amounts of
cefpirome
and dalfopristine/quinupristine combination. A method of treating a patient comprising
the administration of synergistically effective amounts of cefpirome and a dalfopristine/quinupristine
combination. Kits comprising synergistically effective amounts of cefpirome and
a dalfopristine/quinupristine combination are also disclosed.